These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29154283)

  • 1. Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.
    Cuberas-Borrós G; Roca I; Boada M; Tárraga L; Hernández I; Buendia M; Rubio L; Torres G; Bittini Á; Guzmán-de-Villoria JA; Pujadas F; Torres M; Núñez L; Castell J; Páez A
    J Alzheimers Dis; 2018; 61(1):321-332. PubMed ID: 29154283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.
    Boada M; Anaya F; Ortiz P; Olazarán J; Shua-Haim JR; Obisesan TO; Hernández I; Muñoz J; Buendia M; Alegret M; Lafuente A; Tárraga L; Núñez L; Torres M; Grifols JR; Ferrer I; Lopez OL; Páez A
    J Alzheimers Dis; 2017; 56(1):129-143. PubMed ID: 27911295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study.
    Cuberas-Borrós G; Roca I; Castell-Conesa J; Núñez L; Boada M; López OL; Grifols C; Barceló M; Pareto D; Páez A
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4589-4600. PubMed ID: 35867135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study.
    Boada M; López OL; Olazarán J; Núñez L; Pfeffer M; Paricio M; Lorites J; Piñol-Ripoll G; Gámez JE; Anaya F; Kiprov D; Lima J; Grifols C; Torres M; Costa M; Bozzo J; Szczepiorkowski ZM; Hendrix S; Páez A
    Alzheimers Dement; 2020 Oct; 16(10):1412-1425. PubMed ID: 32715623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroimaging in Alzheimer's disease: findings in plasmapheresis with albumin].
    Roca I; Cuberas-Borros G
    Rev Neurol; 2010 Mar; 50 Suppl 5():S19-22. PubMed ID: 20517865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization.
    Boada M; Ortiz P; Anaya F; Hernández I; Muñoz J; Núñez L; Olazarán J; Roca I; Cuberas G; Tárraga L; Buendia M; Pla RP; Ferrer I; Páez A
    Drug News Perspect; 2009; 22(6):325-39. PubMed ID: 19771322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study.
    Boada M; Ramos-Fernández E; Guivernau B; Muñoz FJ; Costa M; Ortiz AM; Jorquera JI; Núñez L; Torres M; Páez A
    Neurologia; 2016 Sep; 31(7):473-81. PubMed ID: 25023458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress.
    Boada M; López O; Núñez L; Szczepiorkowski ZM; Torres M; Grifols C; Páez A
    Alzheimers Dement (N Y); 2019; 5():61-69. PubMed ID: 30859122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study.
    Boada M; López OL; Olazarán J; Núñez L; Pfeffer M; Puente O; Piñol-Ripoll G; Gámez JE; Anaya F; Kiprov D; Alegret M; Grifols C; Barceló M; Bozzo J; Szczepiorkowski ZM; Páez A;
    Alzheimers Dement; 2022 Jul; 18(7):1314-1324. PubMed ID: 34726348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between white matter lesions and regional cerebral blood flow changes during longitudinal follow up in Alzheimer's disease.
    Hanaoka T; Kimura N; Aso Y; Takemaru M; Kimura Y; Ishibashi M; Matsubara E
    Geriatr Gerontol Int; 2016 Jul; 16(7):836-42. PubMed ID: 26245516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study.
    Boada M; Kiprov D; Anaya F; López OL; Núñez L; Olazarán J; Lima J; Grifols C; Barceló M; Rohe R; Prieto-Fernández C; Szczepiorkowski ZM; Páez A
    J Clin Apher; 2023 Feb; 38(1):45-54. PubMed ID: 36305459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease].
    Boada-Rovira M
    Rev Neurol; 2010 Mar; 50 Suppl 5():S9-18. PubMed ID: 20517868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease.
    Matsuda H; Kitayama N; Ohnishi T; Asada T; Nakano S; Sakamoto S; Imabayashi E; Katoh A
    J Nucl Med; 2002 Mar; 43(3):304-11. PubMed ID: 11884488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S; Kanetaka H; Hirao K; Fukasawa R; Namioka N; Hatanaka H; Hirose D; Umahara T; Sakurai H; Hanyu H
    Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer's Disease.
    Valotassiou V; Papatriantafyllou J; Sifakis N; Tzavara C; Tsougos I; Psimadas D; Fezoulidis I; Kapsalaki E; Hadjigeorgiou G; Georgoulias P
    J Alzheimers Dis; 2015; 47(3):773-85. PubMed ID: 26401711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.